Publication | Open Access

Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study

ObesityBreast OncologyObese Postmenopausal PatientsMedicineCancer ManagementGynecologyPhase Ii StudyBreast CancerPharmacotherapyOncologyRadiation OncologyEndocrine-related CancerHer2-negative Breast Cancer